跳至主要内容
临床试验/NCT01246375
NCT01246375Unknown不适用

Prevalence of Osteoporosis in Patients Who Uses Inhaled Steroids

Tel-Aviv Sourasky Medical Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
试验地点
1
主要终点
Diagnosis of Osteoporosis

研究概览

简要总结

The purpose of this research is to determine whether the prevalence of osteoporosis is greater in patients who suffer from Chronic obstructive pulmonary disease (COPD) or Asthma disease and uses inhaled steroids.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
60 Years 至 90 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Man at the minimum age of 60 years.
  • Diagnosed with Chronic Obstructive Pulmonary disease (COPD) or Asthma disease.
  • Usage of the following corticosteroids at the minimal doses indicated, for at least 3 years:
  • Seretide 250/50 mcg Symbicort 320/9 mcg 5.No Diagnosis of thyroid irregularity 6.No diagnosis/treatment for Osteoporosis.

排除标准

  • Usage of systemic steroids more than once during the 12 months prior to the study.
  • Usage of systemic steroids during the month prior to the study.
  • Usage of inhaled steroids in order to treat any other disease except Chronic Obstructive Pulmonary Disease (COPD) or Asthma.

结局指标

主要结局

Diagnosis of Osteoporosis

时间窗: 3

次要结局

未报告次要终点

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验

Prevalence of Osteoporosis in Patients Who Uses... | 临床试验